An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

NCT07288320 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder
Mania

Interventions

DRUG: NBI-1117568
DRUG: Placebo

Sponsor

Neurocrine Biosciences